News

Published on 5 Feb 2025 on Zacks · via Yahoo Finance

Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know


Article preview image

Incyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. 10,...

NASDAQ.INCY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know

Incyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. ...

Zacks · via Yahoo Finance 5 Feb 2025

Incyte's SWOT analysis: pipeline progress faces patent cliff pressure By...

Incyte's SWOT analysis: pipeline progress faces patent cliff pressure

Investing.com 26 Nov 2024

Incyte shares target lifted, buy rating on povorcitinib sales outlook By...

On Monday, Incyte (NASDAQ:INCY) Corporation (NASDAQ:INCY) shares received a positive assessment f...

Investing.com 25 Nov 2024

Goldman Sachs: Incyte Corporation (INCY) Is A Top Growth Investor Stock

We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest...

Insider Monkey · via Yahoo Finance 22 Nov 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% By...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28%

Investing.com 20 Nov 2024

BMO keeps Incyte stock at underperform, price target at $52 By Investing.com

On Tuesday, BMO Capital maintained its Underperform rating for Incyte (NASDAQ:INCY) Corporation...

Investing.com 19 Nov 2024

Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two...

On Monday, Incyte Corporation (NASDAQ:INCY) announced that it will pause enrollment in the ongoin...

Benzinga · via AOL 19 Nov 2024

Nasdaq Gains 100 Points; Lowe's Earnings Beat Views - Lowe's Companies...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining by around 100 ...

Benzinga 19 Nov 2024

Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two...

On Monday, Incyte Corporation (NASDAQ:INCY) announced that it will pause enrollment in the ongoin...

Benzinga · via Yahoo Finance 19 Nov 2024

Incyte Faces Challenges but Remains Focused on Strategic Growth

Incyte Corporation (NASDAQ:INCY) shares plunged 11.26% on Tuesday and here are some significant...

GuruFocus.com · via Yahoo Finance 19 Nov 2024